Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fifth Annual In Vino Vita Benefit and Wine Auction Supports Research and Patient Care at Fox Chase Cancer Center
Now in its fifth year, In Vino Vita has raised nearly $4 million to advance pioneering research and patient care at Fox Chase. It has also evolved into a premier wine event in Philadelphia. Some of the world’s finest winemaking talent will be participating in the event, including Clos Pegase, Chateau d’Esclans, and Champagne Laurent-Perrier.
While enjoying an evening of live music and a multi-course dinner, guests participate in a lively auction with high-end wine and related experiences available to the highest bidders. More than 500 leaders from the fields of healthcare, business, and philanthropy attended the 2017 event.
One of the hallmarks of In Vino Vita is the Special Pledge, in which attendees band together to support a worthwhile project at Fox Chase. This year the Special Pledge will focus on advancing patient care. Funds will be used to acquire new equipment, technology, treatment, and facilities to further improve the patient experience. Previous Special Pledges provided funding for upgraded infusion room patient chairs, an expansion and comprehensive renovation of the surgical family waiting suite, a state-of-the-art immunotherapy lab, and ten early-stage research projects.
Tickets are available at vinovita.org.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427